Neurocrine Biosciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	73,482	85,477	62,816	60,702	45,018	46,506
Market Cap Growth	-16.91%	36.07%	3.48%	34.84%	-3.20%	16.88%
Enterprise Value	70,168	79,652	58,830	57,973	43,273	44,289
Last Close Price	34.08	42.53	32.30	31.58	23.62	25.17
PE Ratio	32.22	40.49	51.85	74.32	90.18	21.99
PS Ratio	5.14	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.59	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.65	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	23.25	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	21.65	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	5.01	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	21.29	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	24.88	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	22.20	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Invested Capital (ROIC)	16.07%	22.51%	22.75%	17.26%	19.95%	54.61%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.10%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.30%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.